IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread

Clinical trial NCT01099631 · COMPLETED

Trial details

NCT number: NCT01099631
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer of the Liver Liver Cancer Hepatoma Liver Neoplasms Biliary Cancer

Start date: 2010-04-01
Primary completion: 2014-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.